MaxCyte ^Investors

MaxCyte is a private equity firm headquartered in Gaithersburg, Maryland, United States, established in 1998 The firm specializes in providing innovative cell-based therapies and has developed a proprietary platform for cell engineering With an investment scale of approximately $175,500,000, MaxCyte focuses on advancing the development of life-saving treatments in the biopharmaceutical sector The company is committed to supporting the growth of its portfolio companies through strategic partnerships and expertise in cellular technology